Wuxi Biologics (Cayman) (WXIBF) Receives a Buy from Jefferies
Jefferies analyst Cui Cui maintained a Buy rating on Wuxi Biologics (Cayman) (WXIBF – Research Report) today and set a price target of ...
Mena FN7d
Wuxi Biologics Reports Solid 2024 Annual Results And Expects Accelerated Growth In 2025
HONG KONG, March 25, 2025 /PRNewswire/ -- WuXi Biologics (Cayman) Inc. ("WuXi Biologics" or "the Group", stock code: 2269), a leading global Contract Research, Development and Manufacturing ...